112 related articles for article (PubMed ID: 31050187)
1. Severe therapy-related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres.
Agrusa JE; Bertuch AA; DiNardo CD; Plon SE; Eckstein OS
Pediatr Blood Cancer; 2019 Aug; 66(8):e27779. PubMed ID: 31050187
[TBL] [Abstract][Full Text] [Related]
2. Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.
Pavlaki KI; Kastrinaki MC; Klontzas M; Velegraki M; Mavroudi I; Papadaki HA
Haematologica; 2012 May; 97(5):743-50. PubMed ID: 22133767
[TBL] [Abstract][Full Text] [Related]
3. Revisiting Telomere Shortening in Cancer.
Okamoto K; Seimiya H
Cells; 2019 Jan; 8(2):. PubMed ID: 30709063
[TBL] [Abstract][Full Text] [Related]
4. The influence of TERC, TERT and ACYP2 genes polymorphisms on plasma telomerase concentration, telomeres length and T2DM.
AlDehaini DMB; Al-Bustan SA; Malalla ZHA; Ali ME; Sater M; Giha HA
Gene; 2021 Jan; 766():145127. PubMed ID: 32937184
[TBL] [Abstract][Full Text] [Related]
5. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
Dai J; Cai H; Zhuang Y; Wu Y; Min H; Li J; Shi Y; Gao Q; Yi L
Respirology; 2015 Jan; 20(1):122-8. PubMed ID: 25346280
[TBL] [Abstract][Full Text] [Related]
6. Telomere length shortening of peripheral blood mononuclear cells in solid-cancer patients undergoing standard-dose chemotherapy might be correlated with good treatment response and neutropenia severity.
Yoon SY; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Acta Haematol; 2007; 118(1):30-7. PubMed ID: 17429195
[TBL] [Abstract][Full Text] [Related]
7. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.
Norberg A; Rosén A; Raaschou-Jensen K; Kjeldsen L; Moilanen JS; Paulsson-Karlsson Y; Baliakas P; Lohi O; Ahmed A; Kittang AO; Larsson P; Roos G; Degerman S; Hultdin M
Eur J Hum Genet; 2018 Jun; 26(6):858-867. PubMed ID: 29483670
[TBL] [Abstract][Full Text] [Related]
8. Telomere Length, TERT, and miRNA Expression.
Slattery ML; Herrick JS; Pellatt AJ; Wolff RK; Mullany LE
PLoS One; 2016; 11(9):e0162077. PubMed ID: 27627813
[TBL] [Abstract][Full Text] [Related]
9. A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma.
Oak E; Bartlett NL
Expert Opin Drug Saf; 2016 Jun; 15(6):875-82. PubMed ID: 27139729
[TBL] [Abstract][Full Text] [Related]
10. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.
Carrillo J; Calvete O; Pintado-Berninches L; Manguan-García C; Sevilla Navarro J; Arias-Salgado EG; Sastre L; Guenechea G; López Granados E; de Villartay JP; Revy P; Benitez J; Perona R
Hum Mol Genet; 2017 May; 26(10):1900-1914. PubMed ID: 28369633
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia.
Eskandari E; Hashemi M; Naderi M; Bahari G; Safdari V; Taheri M
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1515-1521. PubMed ID: 29936725
[TBL] [Abstract][Full Text] [Related]
12. hTERT genetic variation in depression.
Wei YB; Martinsson L; Liu JJ; Forsell Y; Schalling M; Backlund L; Lavebratt C
J Affect Disord; 2016 Jan; 189():62-9. PubMed ID: 26406970
[TBL] [Abstract][Full Text] [Related]
13. Impact of post-brentuximab vedotin consolidation on relapsed/refractory CD30+ Hodgkin lymphomas: a large retrospective study on 240 patients enrolled in the French Named-Patient Program.
Perrot A; Monjanel H; Bouabdallah R; Quittet P; Sarkozy C; Bernard M; Stamatoullas A; Borel C; Bouabdallah K; Nicolas-Virelizier E; Fournier M; Morschhauser F; Brice P;
Haematologica; 2016 Apr; 101(4):466-73. PubMed ID: 26768687
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice.
Raval A; Behbehani GK; Nguyen le XT; Thomas D; Kusler B; Garbuzov A; Ramunas J; Holbrook C; Park CY; Blau H; Nolan GP; Artandi SE; Mitchell BS
PLoS One; 2015; 10(7):e0131722. PubMed ID: 26133370
[TBL] [Abstract][Full Text] [Related]
15. Telomere shortening: a new prognostic factor for cardiovascular disease post-radiation exposure.
M'kacher R; Girinsky T; Colicchio B; Ricoul M; Dieterlen A; Jeandidier E; Heidingsfelder L; Cuceu C; Shim G; Frenzel M; Lenain A; Morat L; Bourhis J; Hempel WM; Koscielny S; Paul JF; Carde P; Sabatier L
Radiat Prot Dosimetry; 2015 Apr; 164(1-2):134-7. PubMed ID: 25274533
[TBL] [Abstract][Full Text] [Related]
16. Cyclophosphamide-based, seven-drug hybrid and low-dose involved field radiation for the treatment of childhood and adolescent Hodgkin disease.
Hamilton VM; Norris C; Bunin N; Goldwein JW; Bunin GR; Lange B; Meadows AT
J Pediatr Hematol Oncol; 2001 Feb; 23(2):84-8. PubMed ID: 11216711
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
Eichenauer DA; Thielen I; Haverkamp H; Franklin J; Behringer K; Halbsguth T; Klimm B; Diehl V; Sasse S; Rothe A; Fuchs M; Böll B; von Tresckow B; Borchmann P; Engert A
Blood; 2014 Mar; 123(11):1658-64. PubMed ID: 24478403
[TBL] [Abstract][Full Text] [Related]
18. The case for chemotherapy only for localized Hodgkin lymphoma.
Straus DJ
Oncologist; 2009 Dec; 14(12):1225-31. PubMed ID: 20007643
[TBL] [Abstract][Full Text] [Related]
19. Use of U-STELA for Accurate Measurement of Extremely Short Telomeres.
Serakinci N; Cagsin H; Mavis M
Methods Mol Biol; 2019; 2045():217-224. PubMed ID: 29542055
[TBL] [Abstract][Full Text] [Related]
20. Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsia.
Sukenik-Halevy R; Amiel A; Kidron D; Liberman M; Ganor-Paz Y; Biron-Shental T
Am J Obstet Gynecol; 2016 Feb; 214(2):283.e1-283.e7. PubMed ID: 26321036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
